A carregar...
Efficacy and Safety of Canagliflozin in Kidney Transplant Patients
INTRODUCTION: There is no report of efficacy and safety of canagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor in post kidney transplant patients with diabetes. MATERIALS AND METHODS: A pilot study was undertaken in stable renal transplant recipients with preexisting diabetes or new on...
Na minha lista:
| Publicado no: | Indian J Nephrol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668319/ https://ncbi.nlm.nih.gov/pubmed/31423063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijn.IJN_2_18 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|